vs

Side-by-side financial comparison of Artisan Partners Asset Management Inc. (APAM) and MADRIGAL PHARMACEUTICALS, INC. (MDGL). Click either name above to swap in a different company.

Artisan Partners Asset Management Inc. is the larger business by last-quarter revenue ($335.5M vs $321.1M, roughly 1.0× MADRIGAL PHARMACEUTICALS, INC.). Artisan Partners Asset Management Inc. runs the higher net margin — 35.2% vs -18.2%, a 53.4% gap on every dollar of revenue. On growth, MADRIGAL PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (210.8% vs 12.9%). Artisan Partners Asset Management Inc. produced more free cash flow last quarter ($171.6M vs $-133.8M).

Artisan Partners is an American asset management company headquartered in Milwaukee, Wisconsin. Outside the United States, the company has offices in Dublin, Hong Kong, London, Singapore and Sydney.

Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases, such as primary biliary cirrhosis (PBC) now called primary biliary cholangitis, non-alcoholic fatty liver disease, cirrhosis, portal hypertension, primary sclerosing cholangitis and also the intestinal disorder, bile acid diarrhea.

APAM vs MDGL — Head-to-Head

Bigger by revenue
APAM
APAM
1.0× larger
APAM
$335.5M
$321.1M
MDGL
Growing faster (revenue YoY)
MDGL
MDGL
+197.8% gap
MDGL
210.8%
12.9%
APAM
Higher net margin
APAM
APAM
53.4% more per $
APAM
35.2%
-18.2%
MDGL
More free cash flow
APAM
APAM
$305.5M more FCF
APAM
$171.6M
$-133.8M
MDGL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
APAM
APAM
MDGL
MDGL
Revenue
$335.5M
$321.1M
Net Profit
$118.1M
$-58.6M
Gross Margin
Operating Margin
39.2%
-18.6%
Net Margin
35.2%
-18.2%
Revenue YoY
12.9%
210.8%
Net Profit YoY
34.9%
1.4%
EPS (diluted)
$1.36
$-2.55

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
APAM
APAM
MDGL
MDGL
Q4 25
$335.5M
$321.1M
Q3 25
$301.3M
$287.3M
Q2 25
$282.7M
$212.8M
Q1 25
$277.1M
$137.3M
Q4 24
$297.1M
$103.3M
Q3 24
$279.6M
$62.2M
Q2 24
$270.8M
Q1 24
$264.4M
$0
Net Profit
APAM
APAM
MDGL
MDGL
Q4 25
$118.1M
$-58.6M
Q3 25
$66.8M
$-114.2M
Q2 25
$67.6M
$-42.3M
Q1 25
$61.1M
$-73.2M
Q4 24
$87.5M
$-59.4M
Q3 24
$73.0M
$-107.0M
Q2 24
$57.6M
Q1 24
$59.5M
$-147.5M
Gross Margin
APAM
APAM
MDGL
MDGL
Q4 25
Q3 25
Q2 25
Q1 25
96.7%
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
APAM
APAM
MDGL
MDGL
Q4 25
39.2%
-18.6%
Q3 25
33.8%
-39.7%
Q2 25
28.2%
-22.2%
Q1 25
31.2%
-57.8%
Q4 24
36.7%
-64.8%
Q3 24
33.3%
-187.1%
Q2 24
32.0%
Q1 24
29.4%
Net Margin
APAM
APAM
MDGL
MDGL
Q4 25
35.2%
-18.2%
Q3 25
22.2%
-39.8%
Q2 25
23.9%
-19.9%
Q1 25
22.1%
-53.4%
Q4 24
29.5%
-57.5%
Q3 24
26.1%
-172.0%
Q2 24
21.3%
Q1 24
22.5%
EPS (diluted)
APAM
APAM
MDGL
MDGL
Q4 25
$1.36
$-2.55
Q3 25
$0.93
$-5.08
Q2 25
$0.94
$-1.90
Q1 25
$0.82
$-3.32
Q4 24
$0.99
$-2.50
Q3 24
$1.03
$-4.92
Q2 24
$0.80
Q1 24
$0.84
$-7.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
APAM
APAM
MDGL
MDGL
Cash + ST InvestmentsLiquidity on hand
$198.7M
Total DebtLower is stronger
$190.0M
$339.9M
Stockholders' EquityBook value
$438.8M
$602.7M
Total Assets
$1.6B
$1.3B
Debt / EquityLower = less leverage
0.43×
0.56×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
APAM
APAM
MDGL
MDGL
Q4 25
$198.7M
Q3 25
$295.7M
Q2 25
$186.2M
Q1 25
$183.6M
Q4 24
$100.0M
Q3 24
$232.7M
Q2 24
Q1 24
$622.5M
Total Debt
APAM
APAM
MDGL
MDGL
Q4 25
$190.0M
$339.9M
Q3 25
$190.0M
$339.8M
Q2 25
$200.0M
$118.4M
Q1 25
$200.0M
$118.0M
Q4 24
$200.0M
$117.6M
Q3 24
$200.0M
$117.1M
Q2 24
$200.0M
Q1 24
$200.0M
$116.1M
Stockholders' Equity
APAM
APAM
MDGL
MDGL
Q4 25
$438.8M
$602.7M
Q3 25
$402.1M
$625.7M
Q2 25
$381.8M
$696.0M
Q1 25
$356.5M
$710.6M
Q4 24
$388.9M
$754.4M
Q3 24
$372.1M
$777.2M
Q2 24
$341.2M
Q1 24
$320.3M
$850.8M
Total Assets
APAM
APAM
MDGL
MDGL
Q4 25
$1.6B
$1.3B
Q3 25
$1.6B
$1.4B
Q2 25
$1.4B
$1.0B
Q1 25
$1.4B
$996.6M
Q4 24
$1.6B
$1.0B
Q3 24
$1.6B
$1.1B
Q2 24
$1.5B
Q1 24
$1.5B
$1.1B
Debt / Equity
APAM
APAM
MDGL
MDGL
Q4 25
0.43×
0.56×
Q3 25
0.47×
0.54×
Q2 25
0.52×
0.17×
Q1 25
0.56×
0.17×
Q4 24
0.51×
0.16×
Q3 24
0.54×
0.15×
Q2 24
0.59×
Q1 24
0.62×
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
APAM
APAM
MDGL
MDGL
Operating Cash FlowLast quarter
$172.0M
$-133.5M
Free Cash FlowOCF − Capex
$171.6M
$-133.8M
FCF MarginFCF / Revenue
51.2%
-41.7%
Capex IntensityCapex / Revenue
0.1%
0.1%
Cash ConversionOCF / Net Profit
1.46×
TTM Free Cash FlowTrailing 4 quarters
$420.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
APAM
APAM
MDGL
MDGL
Q4 25
$172.0M
$-133.5M
Q3 25
$40.4M
$79.8M
Q2 25
$50.9M
$-47.1M
Q1 25
$157.9M
$-88.9M
Q4 24
$372.8M
$-104.5M
Q3 24
$112.8M
$-67.0M
Q2 24
$75.9M
Q1 24
$147.0M
$-149.2M
Free Cash Flow
APAM
APAM
MDGL
MDGL
Q4 25
$171.6M
$-133.8M
Q3 25
$40.4M
$79.0M
Q2 25
$50.9M
Q1 25
$157.7M
Q4 24
$371.3M
$-104.7M
Q3 24
$112.4M
$-67.8M
Q2 24
$75.2M
Q1 24
$146.9M
$-149.5M
FCF Margin
APAM
APAM
MDGL
MDGL
Q4 25
51.2%
-41.7%
Q3 25
13.4%
27.5%
Q2 25
18.0%
Q1 25
56.9%
Q4 24
125.0%
-101.3%
Q3 24
40.2%
-109.0%
Q2 24
27.8%
Q1 24
55.6%
Capex Intensity
APAM
APAM
MDGL
MDGL
Q4 25
0.1%
0.1%
Q3 25
0.0%
0.3%
Q2 25
0.0%
0.0%
Q1 25
0.1%
0.0%
Q4 24
0.5%
0.2%
Q3 24
0.1%
1.3%
Q2 24
0.2%
Q1 24
0.0%
Cash Conversion
APAM
APAM
MDGL
MDGL
Q4 25
1.46×
Q3 25
0.60×
Q2 25
0.75×
Q1 25
2.58×
Q4 24
4.26×
Q3 24
1.54×
Q2 24
1.32×
Q1 24
2.47×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

APAM
APAM

Segment breakdown not available.

MDGL
MDGL

Rebates Customer Fees Credits Co Pay Assistance And Other$208.5M65%
Other$76.0M24%
Chargebacks Discounts For Prompt Pay And Other Allowances$36.6M11%

Related Comparisons